EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanwar, Y. S.
Right arrow Articles by Danesh, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanwar, Y. S.
Right arrow Articles by Danesh, F. R.
Experimental Biology and Medicine 233:4-11 (2008)
doi: 10.3181/0705-MR-134
© 2008 Society for Experimental Biology and Medicine


MINIREVIEW

Diabetic Nephropathy: Mechanisms of Renal Disease Progression

Yashpal S. Kanwar*,1, Jun Wada{dagger}, Lin Sun*, Ping Xie*, Elisabeth I. Wallner{ddagger}, Sheldon Chen{ddagger}, Sumant Chugh{ddagger} and Farhad R. Danesh{ddagger}

* Department of Pathology, Northwestern University School of Medicine, Chicago, Illinois 60611; {dagger} Department of Medicine, Okayama University School of Medicine, Okayama, 700-8558 Japan; and {ddagger} Department of Medicine, Northwestern University School of Medicine, Chicago, Illinois 60611

To whom requests for reprints should be addressed at 1 Department of Pathology, Northwestern University Medical School, Chicago, IL 60611. E-mail: y-kanwar{at}northwestern.edu

Diabetic nephropathy is characterized by excessive amassing of extracellular matrix (ECM) with thickening of glomerular and tubular basement membranes and increased amount of mesangial matrix, which ultimately progress to glomerulosclerosis and tubulo-interstitial fibrosis. In view of this outcome, it would mean that all the kidney cellular elements, i.e., glomerular endothelia, mesangial cells, podocytes, and tubular epithelia, are targets of hyperglycemic injury. Conceivably, high glucose activates various pathways via similar mechanisms in different cell types of the kidney except for minor exceptions that are related to the selective expression of a given molecule in a particular renal compartment. To begin with, there is an obligatory excessive channeling of glucose intermediaries into various metabolic pathways with generation of advanced glycation products (AGEs), activation of protein kinase C (PKC), increased expression of transforming growth factor-β (TGF-β), GTP-binding proteins, and generation of reactive oxygen species (ROS). The ROS seem to be the common denominator in various pathways and are central to the pathogenesis of hyperglycemic injury. In addition, there are marked alterations in intraglomerular hemodynamics, i.e., hyperfiltration, and this along with metabolic derangements adversely compounds the hyperglycemia-induced injury. Here, the information compiled under various subtitles of this article is derived from an enormous amount of data summarized in several excellent literature reviews, and thus their further reading is suggested to gain in-depth knowledge of each of the subject matter.

Key Words: hyperglycemia • advance glycation products • protein kinase C • GTP binding proteins • reactive oxygen species • hypertension




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
R. V. Durvasula and S. J. Shankland
Activation of a local renin angiotensin system in podocytes by glucose
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F830 - F839.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Experimental Biology and Medicine.